IssuerAnnouncementDetailsV2Portlet
Actions
Al Hammadi Holding Co. Announces Signing of a Strategic Cooperation Agreement with A.C. Milan S.p.A.
| Element List | Explanation |
|---|---|
| Introduction | Al Hammadi Holding Company (“the Company”) announces that it has signed a strategic cooperation agreement with A.C. Milan S.p.A. (“the Club”), on the sidelines of the Middle East Sports Investment Forum (MESIF) held in Riyadh. |
| Date of Announcement of the Award | 2026-01-28 Corresponding to 1447-08-09 |
| Contract Subject Matter | Under this agreement, the Company and Al Hammadi Hospitals Group obtained exclusive rights as the Official Medical & Rehabilitation Partner of AC Milan in the Kingdom of Saudi Arabia. The agreement focuses on developing medical, rehabilitation and performance-related collaboration between the Club’s medical experts and Al Hammadi Hospitals Group’s clinical facility in Riyadh. |
| The Entity with Which the Contract was Signed | A.C. Milan S.p.A. |
| Date of Signing the Contract | 2026-01-28 Corresponding to 1447-08-09 |
| Contract Value | Total contract value of SAR 54,500,000 (fifty-four million and five hundred thousand Riyals). |
| Contract Details | The agreement is structured as a multi-year project ending on June 30, 2033, with the total contract value to be paid in scheduled installments throughout the term. The Company expects this collaboration to enhance its corporate profile in advanced sports medicine, strengthen its clinical capabilities, and support the development of specialized rehabilitation services in the Kingdom. |
| Contract Duration | 8 years |
| Financial Impact and the Relevant Period | The transaction is expected to have a positive impact on the Company’s profitability in the year of 2026 and subsequent years. |
| Related Parties | None |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 25.94
Net Change 0.14 (+0.54%)
Value Traded (Sar) 2,686,143.04
Volume Traded 104,249
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions